September 17, 2015

Aurobindo Pharma’s received approval from the Food and Drug Administration this week for its generic of Roxane Laboratories’ Dolophine (methadone HCL) tablets. 

September 16, 2015

Caridiologist Robert Califf is currently the FDA’s deputy commissioner for medical products and tobacco, a post he has held since March.

September 16, 2015

A new drug before the Food and Drug Administration would track adherence. 

September 14, 2015

Mylan announced Monday that it had launched its generic version of Pfizer’s Unasyn (ampicillin and subactam) injection. 

September 11, 2015

DSN examines chain pharmacy, including in-depth coverage of retail clinics, technology, automation, medication synchronization and generics, in this multi-page report.

September 4, 2015

The Council for Responsible Nutrition this week came out in support of the Food and Drug Administration taking action against marketing bulk pure powdered caffeine to consumers and its issuance of warning letters to five powdered caffeine distributors.

September 4, 2015

AstraZeneca on Thursday announced that the Food and Drug Administration approved Brilinta (ticagrelor) tablets at a 60 mg dose for patients with a history of heart attack beyond the first year.

September 4, 2015

The Food and Drug Administration this week approved expanded labeling for Janssen Biotech’s rheumatoid arthritis treatment Simponi Aria (golimumab for infusion).

August 31, 2015

The guidance was outlined in a blog post by Janet Woodcock, director of the FDA’s center for drug evaluation and research, and Karen Midthum, director of the FDA’s center for biologics evaluation and research.

August 28, 2015

Amgen announced Friday that the Food and Drug Administration had approved its new cholesterol treatment Repatha (evolocumab) injection.

August 28, 2015

The Food and Drug Administration has a new diabetes treatment developed by Boehringer Ingelheim Pharmaceuticals and Eli Lilly and Co.

August 27, 2015

Aurobindo Pharma Limited announced Thursday that it had received approval from the Food and Drug Administration for its entecavir tablets in 0.5- and 1-mg dosage strengths. 

August 25, 2015

Glucose monitoring device company Dexcom announced Tuesday that the Food and Drug Administration had approved its G5 Mobile Continuous Glucose Monitoring System.

August 20, 2015

DSN examines chain pharmacy, including in-depth coverage of retail clinics, technology, automation, medication synchronization and generics, in this multi-page report.

August 20, 2015

Cosmederm Bioscience’s Tri-Calm OTC itch relief solution is quickly climbing the anti-itch treatment product chart with growth of 148.2% to a dollar base of $4.9 million for the 52 weeks ended June 14 across total U.S. multi-outlets, according to IRI.

August 19, 2015

The Food and Drug Administration handed down its anticipated approval of Sprout Pharmaceuticals’ Addyi, a treatment for women with generalized hypoactive sexual desire disorder. 

August 18, 2015

Aurobindo Pharma Limited announced Tuesday that it had received approval from the Food and Drug Administration for its over-the-counter cetirizine hydrochloride in 5- and 10-mg dosage strengths.

August 12, 2015

The online guide includes information about the benefits and risks of vaccination, the types of vaccines children routinely receive as well as a section with questions that parents are asking about vaccination.

August 10, 2015

The Food and Drug Administration approved Mylan's Lidocaine Patch 5%, a generic version of Endo Pharmaceutical's Lidoderm.

August 10, 2015

In order to ensure that patients receive treatment for periodic paralysis, Taro will be partnering with Diplomat Pharmacy, where patients and caregivers will receive treatment access and support. 

August 10, 2015

The company’s memantine hydrochloride tablets, available in 5- and 10-mg dosage strengths, are meant to treat dementia associated with Alzheimer’s disease.

August 6, 2015

Aurobindo Pharma Limited on Tuesday received approval from the Food and Drug Administration for its alprazolam tablets, a generic version of Xanax. 

August 5, 2015

Manufacturers Atrium, Aspen Group, Nutri-Pak of Wisconsin will have to get a special clearance from FDA before producing supplements again.